| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 3 | / | 2024 | |||||||
| Date of issue: | 2024-01-19 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| Acquisition of treasury shares | |||||||||||
| Official market - legal basis | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 2 of the Commission Delegated Regulation (EU) 2016/1052 Krka, d. d., Novo mesto announces: With a reference to the public notice from 20 July 2023, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 12 January 2024 up to and including 18 January 2024. Krka acquired 3,757 treasury shares in the total value of EUR 405,621 on the Ljubljana Stock Exchange as follows: - on 12 January 2024: 690 shares at a VWAP of EUR 112.93, - on 15 January 2024: 807 shares at a VWAP of EUR 113.04, - on 16 January 2024: 804 shares at a VWAP of EUR 113.75, - on 17 January 2024: 502 shares at a VWAP of EUR 113.57 and - on 18 January 2024: 772 shares at a VWAP of EUR 114.00. Price is calculated as volume weighted average price (VWAP). Ilirika d.d., Intercapital d.d. and NLB d.d. were brokers in these transactions. Detailed report on acquisition of treasury shares attached. The total number of treasury shares prior to these transactions was 1,921,534 representing 5.860% of all shares issued. The total number of treasury shares after these transactions is 1,925,109 representing 5.870% of all shares issued. The notice will be published on the Company's website (www.krka.biz) from 19 January 2024 onwards, for a period of at least 5 years. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Detailed report on acquisition of treasury shares.pdf | Detailed report on acquisition of treasury shares | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2024-01-19 | Jože Colarič | President of Management Board and CEO | |||
